MedTrace Logo

The Effects of Zinc Di-(Dibutyryl Lisinate) on Skin Health and the Skin Microbiome in Photoaged Skin

NCT06096649 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-10-24

No results posted yet for this study

Summary

This study is a double-blind randomized vehicle-controlled study assessing how Zinc Di-(dibutyryl lisinate) (Z-DBL) influences skin biophysical measures such as skin hydration, transepidermal water loss, and elasticity, as well as its effects on the skin microbiome of photoaged skin.

Conditions

  • Photoaging

Interventions

OTHER

Topical Vehicle + Zinc Di-(dibutyryl lisinate)

Instructions: Apply to the entire face twice daily - morning and evening

OTHER

Topical Vehicle

Instructions: Apply to the entire face twice daily - morning and evening

Sponsors & Collaborators

  • Sytheon Ltd.

    collaborator INDUSTRY

  • Integrative Skin Science and Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-15
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06096649 on ClinicalTrials.gov